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INTRODUCTION 
 
 
 
 
 
 
 
 
  
 
INTRODUCTION 
 
 
 Colorectal malignancies are 3rd most common malignancy in India 
preceded only by lung and breast cancer.   
 
Colorectal malignancies if diagnosed in early stages, is curable by 
surgical treatment with minimal morbidity and mortality. 
 
Further, colorectal carcinoma is a model for all aspects of cancer 
study, namely, carcinogenesis, molecular genesis, prevention and early 
diagnosis and a multi modality approach to treatment. 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
AIM OF STUDY 
 
 
 
 
 
 
 
  
 
AIM OF STUDY 
 
• An observational study on colorectal malignancy pertaining to 
natural history of disease, etiology, mode of presentation, site of 
occurrence, mode of treatment, prognostic factors and out come of 
treatment. 
 
• To study various treatment modalities given at Thanjavur Medical 
College Hospital and their outcome with reference to quality and 
quantum of life. 
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REVIEW OF LITERATURE 
 
Gut is derived from endoderm. Caecal bud gives rise to caecum 
and appendix. The ascending colon, right 2/3 of Transverse colon 
develops from the postarterial segment of the midgut loop.  Left 1/3 of 
the Transverse colon and descending colon is derived from hind gut. 
Rectum is derived from the dorsal subdivision of the Cloaca.  After its 
formation, the gut undergoes rotation.  As a result the caecum and 
ascending colon come to lie on the right side; Jejunum and ileum lie 
mainly in the left half of the abdominal cavity. 
Large Intestine Gross anatomy: 
 Terminal part of gastro intestinal tract.  Total length averages 
about 1.5 meters.  It comprises of caecum, ascending colon, Transverse 
colon, descending colon, sigmoid colon, and rectum.  Colon differ from 
rest of GIT in having Larger diameter, Taenia coli, Appendices 
Epiploicae and Haustrations and these feature are absent in Appendix 
and Rectum. 
  
Taenia coli 
 There are 3 bands of longitudinal muscle present in the outer wall 
of the large intestine.  In the appendix and rectum, these bands spread 
out to form a continuous layer.  
Appendices Epiploicae 
 They are peritonial pockets containing fat present in the large 
intestinal wall.  They increase in size and number as they progress 
distally from the caecum to the sigmoid colon.  
 The diameter of the colon gradually decreases as we move from 
right to left.  This along with harder faeces makes obstruction more 
common in left side malignancies. 
CAECUM 
 It is covered by Peritoneum on all the sides.  It measures about 
7cm in length and breath. 
 Ileocaecal junction is variable.   The opening is guarded by ileo 
caecal valve which prevents reflux of caecal contents into the Ileum. 
Ascending colon 
 Measures about 10 – 20 cm covered on all sides by peritoneum 
except the posterior wall.  It ends at hepatic flexure where the transverse 
colon begins. 
  
Transverse colon: 
 Completely covered by peritoneum. Longest part of large intestine 
measures about 40 – 70 cm in length suspended by Transverse 
mesocolon, which is in turn attached to II part of duodenum, head and 
body of pancreas. 
 Transverse meso colon contains middle colic Artery and Vein, 
branch of RT colic Artery and Vein, nerves and lymphatics.  Transverse 
colon is fixed on either ends by splenic and hepatic flexures. 
 It is attached to the stomach by gastro colic omentum. 
Descending Colon: 
 Less than 30cm long extends from splenic flexure to 5 cm above 
inguinal ligament, covered on all sides except on the posterior side by 
peritoneum. 
Sigmoid colon: 
 It is completely surrounded by peritoneum suspended by sigmoid 
mesocolon length varies from 50 – 80 cm.  It continues as rectum at the 
rim of true pelvis at the level of S3.  Base of sigmoid mesocolon starts at 
the end of the descending colon, ascending on external iliac vessels to 
the midpoint of common iliac artery. 
Rectum 
 Lies in the True pelvis measure about 15 cms.  It follows the 
curvature of the sacrum.   
  
 Lowest part of rectum more capacious and is known as ampulla.  
In the coronal plane it forms S shaped curve which leads on to formation 
of values of Houston. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Rectouterine or rectovesical pouch : 
 Inferiorly rectum and surrounding tissue are separated by 
denonviller’s fascia in the anterior part.  Posterior rectum and meso 
rectum covered by Waldeyer’s fascia. 
 Circumferential areolar tissue below the peritoneal reflection 
which carries blood supply and lymphatic drainage is known as 
mesorectum.   
Blood supply 
 Ascending colon 
 Proximal 2/3 of Transverse colon 
Distal 1/3 of Transverse colon, 
descending colon, Sigmoid colon 
Splenic flexure lies in watershed area between L colic and middle 
colic A. 
Rectum supplied by superior rectal A from IMA ,middle and  
inferior rectal A from internal iliac A. 
Venous drainage: 
 Colon – vein accompany artery  
 Rectum – Superior rectal vein to portal vein 
         Middle and inferior rectal vein 
- Systemic circulation. 
Since part of the Rectum drains into systemic circulation, 
pulmonary metastasis more common in distal rectal malignancies. 
Right colic, Ileo colic 
and middle colic 
branches of superior 
mesenteric Artery. 
Inferior mesenteric A 
through L colic and 
sigmoid
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Lymphatic drainage: 
Colon 
 Lymphatic drainage is extensive comprises of Epicolic nodes adjacent 
to colon, paracolic nodes alone the marginal vessels which form tier I and II 
nodes, Intermediate nodes along larger arteries and fourth tier nodes along 
superior and inferior mesenteric arteries which form the principle nodes.  
When tier IV nodes are involved the disease is incurable. 
 Rectum – majority drain along inferior mesenteric Artery. 
 Lower rectum drains laterally along the middle and inferior rectal 
A to Internal iliac nodes. 
Nerve supply 
 Sympathetic – Hypo gastric nerve from hypo gastric plexus. 
 Parasympathetic – nervierigentes from pelvicplexus. 
 Preservation of autonomic nerves important during surgery to prevent 
impotence. 
Histology 
 Wall of colon comprises of 
1. Mucosa – surface epithelium (columnar) 
     Lamina propria 
     Muscularis mucosa 
2. Submucosa 
3. Muscular layer  
4. Sub serosa 
5. Serosa 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LARGE INTESTINE – HISTOLOGY 
 
 
MUCOSA 
SUBMUCOSA 
MUSCULARIS MUCOSA 
SEROSA 
  
Physiology of colon 
 About 1000 ml of ileal contents containing 90% water are 
discharged into the caecum of which only 100 – 200ml of water is 
excreted in faeces. Normal faeces is composed of 70% water and 30% 
solids, about 50% of solids are bacteria. 
 Nutrients such as glucose, amino acids, fatty acids and vitamins 
can be absorbed slowly through the colonic wall .sodium absorption is 
very efficient.  Potassium is actively excreted .frequency of bowel 
movements ranges from once in 8 hours to once in 2 – 3 days. 
3 patterns of motor activity: 
1. Segmentation – most common type 
2. Mass movements – infrequent 
3. Retrograde peristalsis – annular contractions moving proximally. 
Gastro colic reflex 
 It refers to increased ileal emptying, increased mass movements 
and urge to defecate on eating. 
 In general residue from meal reaches caecum after 4 hours and 
rectosigmoid by 24 hours. 
Microbiology of colon 
 Microbes exist in symbiotic relationship with human bacteria 
degrades bile pigments, gives characteristic faecal odor, supply vitamin 
K to the host.   
  
Indicted in pathogenesis of carcinoma of large bowel.  99% of 
bacterial flora is anaerobic. Bacterioides Fragilis is most prevalent 
Anerobic bacteria. Aerobic bacteria are mainly Echerichia Coli and 
Steptococcus fecalis.  Bacterial flora is readily altered by administration 
of oral Neomycin. 
COLORECTAL MALIGNANCY 
ETIOLOGY  
 It has long been postulated that colorectal cancer may be caused or 
promoted by environmental factors, especially by dietary factors that 
affect the enteric milieu. 
 Factors involved in colorectal carcinogenesis: 
• High fat and high cholesterol diet 
• Fecapentanes 
• 3-Ketosteroids 
• Pyrolysis products 
• Insufficent dietary calcium 
• Bile acids 
• Faecal p11 
Although it is not possible to identify a specific cause of colon 
cancer, epidemologic studies of nutritional habits by Sir Denis Burkitt 
revealed clear association of human colorectal cancer with certain diets, 
such as those rich in animal fats and meat and poor in fibre.  
  
Both the type and quantity of fat are important during the 
promotion stage of carcinogenesis. 
Populations that consume more fat have more bile acid secretion 
and an increased incidence of colon cancer.  Cholecystectomy results in 
high levels of bile acids in the stool and may be associated with greater 
frequency of right-sided colon cancer. It is the free and not the total bile 
acid concentration that is critical. 
Calcium salts appear to modulate the damage by reducing the 
concentration of free bile acids through the formation of insoluble bile 
salt complexes. 
PREVENTION 
Prevention of colorectal cancer can be defined as primary or 
secondary. 
Primary prevention 
Is the identification and eradication of factors responsible for 
colorectal cancer. A variety of dietary prescriptions are being tested.  
Increased dietary fibre is of value.  Of the many types of fibres, cellulose 
and bran fibres are more effective in reducing carcinogenesis than other 
fibres. Increased fat and cholesterol ingestion can be associated with an 
increased risk for colorectal cancer.  Persons with an increased intake of 
dietary vitamin D and calcium have a decreased risk for colon cancer. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PUETZ – JEGHER’S SYNDROME 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Secondary prevention 
 Involves identification and removal of the precancerous lesions 
(neoplastic polyps) and treating patients who are genetically or otherwise 
at a very high risk of developing colorectal cancer. 
CLINICAL RISK FACTORS 
Genetic 
(A) Familial polyposis syndromes 
a. Familial adenomatous polyposis (FAP) syndrome 
b. Gardner syndrome 
c. Oldfield syndrome 
d. Turcot syndrome 
(B) Hereditary nonpolyposis colorectal cancer (HNPCC) – (Lynch I 
and II syndromes) 
(C) Hereditary flat adenoma syndrome (HFAS) 
Other factors 
• Ulcerative colitis 
• History of previous colon cancer or polyps  
• Irradiation of pelvis 
• Prior cholecystectomy or ureterosigmoidostomy 
• Peutz-jeghers syndrome and Juvenile polyposis syndrome 
although heritable do not carry the increased risk of malignancy. 
 
 
 
 
 
 
  
Familial Adenomatous Polyposis (FAP) syndrome 
 The disease is inherited as an autosomal dominant triat.  The 
affected persons develop adenomatous polyps in the entire colon.  The 
polyps are not present at birth but by late adolescence, more than a 1000 
may manifest.  By the fourth decade, all the patients develop colonic 
cancer.  Careful evaluation of family members by colonoscopy is 
necessary.  It is also associated with ampullary adenomas, which can 
turn into ampullary cancer.  Even the intervening colonic mucosa shows 
increased proliferation. 
Gardner syndrome 
 Is rarer than FAP and is inherited as an autosomal dominant trait.  
Here, in addition to small and large bowel polyps, desmoid tumors of the 
mesentery and abdominal wall, lipomas, sebaceous cysts, osteomas, and 
fibromas are also seen. 
Oldfield syndrome 
 Consists of multiple sebaceous cysts, polyposis, and 
adenocarcinoma. 
Turcot syndrome 
 Is an autosomal recessive condition associated with malignant 
central nervous system tumours, in addition to bowel polyposis. 
 
 
  
HEREDITARY NONPOLYPOSIS COLORECTAL CANCER 
(HNPCC) 
Lynch I syndrome 
Is inherited as an autosomal dominant with multiple colon cancers 
in the proximal colon at an early age. 
Lynch II syndrome 
Also has an autosomal dominant inheritance with multiple colon 
and extra colon adenocarcinomas (familial adenocarcinomatosis) 
involving the ovary, pancreas, lactiferous duct, endometrium, and 
stomach. 
Hereditary flat adenoma syndrome (HFAS) 
 In this, flat adenomas with diameters greater than 5mm show 
aneuploidy and 80 percent of them turn malignant. 
Ulcerative colitis  
 For patients with ulcerative colitis, the incidence of malignancy 
increases with the extent of bowel involvement, age at onset, severity, and 
duration of the disease.  The incidence of colorectal cancer in patients with 
ulcerative colitis is 5.7 times higher.  Patients with pancolitis for 30 years have 
more than 35 per cent chance of developing bowel cancer. 
Previous malignant disease 
 Patients who have undergone treatment for a large bowel 
adenocarcinoma are at the three-fold risk of a second colorectal tumour. 
 Irradiation of the pelvis enhances the risk of sigmoid cancer. 
 Previous cholecystectomy or ureterosigmodiostomy increases the risk 
of large bowel cancer. 
  
SCREENING 
Population- based screening is not cost-effective in India due to 
the relatively low incidence of colorectal cancer.  However, early 
detection of this cancer is associated with a significant reduction in 
mortality.  Screening should be confined to the high-risk groups as 
mentioned above. 
Screening methods  
Digital rectal examination:  
Most important clinical examination. 75% rectal cancers are 
palpable. We can find out exact length from anal verge, nature of lesion, 
extent, circumference, mobility and fixity to surrounding structures. Growth 
in redundant sigmoid colon, Pelvic deposits of proximal colon, can also 
be made out.  
Flexible sigmoidoscopy:  
Length 60cm - can reach upto splenic flexure, 50-60% cancers are 
within its reach. 
Advantage: 
Biopsy & procedure  OP procedure  
Simple preparation  Better pt compliance  
Availability and expertise not a problem  
With DCBE – cost effective screening tool.  Supplemented with 
colonoscopy if any lesion found. 
  
Faecal occult blood testing: 
Important screening test 
Three kind of tests based on i. Oxidation of Guaiac by Heme  
ii. Detection of porpyrins  iii. Detection of human Hb. 
Advantages: Low cost, no risk  
Disadvantages:  
I. Not all cancers bleed          II. All bleeding is not due to cancer 
III. Some cancers bleed intermittently IV. Influenced by drugs and diets.  
 Screening recommendations for high-risk groups 
1. Yearly faecal occult blood tests 
2. Flexible sigmoidoscopy every 3 to 5 years beginning at the age of 
40 years. 
3. In ulcerative colitis, colonoscopy with multiple biopsies of 
elevated and suspicious lesions is done every 2 years. 
CLINICAL FEATURES 
Specific 
Change in bowel habits 
Intermittent abdominal pain 
 Palpable mass (common with right colon cancer) 
Bleeding 
Acute or as red blood mixed with stool 
Occasionally – melaena in a right colon cancer  
Chronic occult blood loss with iron deficiency anaemia and 
weakness. 
  
Obstruction 
 Obstruction is most commonly associated with cancer of the left 
colon.  If the ileocaecal valve competent, patients manifest as an acute 
abdomen with a closed loop obstruction.  If the ileocaecal valve 
incompetent, the obstruction is more insidious with rasing constipation 
and abdominal distension over many days. 
Perforation – acute or chronic 
 Acute perforation, especially of the caecum, is clinically similar to 
appendicitis with pain, fever, and a palpable mass. 
 Chronic perforation with an internal fistula (e.g., colo vesical) may 
present with recurrent urinary tract infections or pneumaturia. 
PATHOLOGY 
 Appearance 
Proliferative (exophytic) – right-sided cancers are usually 
proliferative 
Ulcerative 
Stenosing (annular) – left-sided cancers tend to grow in an annular 
fashion 
World Health Organisation (WHO) classification  
Adenocarcinoma 
Colloid carcinoma  
Mucinous adeno carcinoma 
  
Signet ring 
 Squamous cell carcinoma 
 Adenosquamous carcinoma 
 Undifferentiated carcinoma 
 Carcinoid tumours 
 Sarcoma 
Stage of differentiation 
Grade 1 – well differentiated 
Grade 2 – intermediate 
Grade 3 – poorly differentiated 
SPREAD 
(a) Local invasion 
a. Circumferential growth,  
b. Lateral transmural penetration, and 
c. Longitudinal spread 
(b) Lymphatic extension 
Stepwise involvement of lymph nodes:  
Paracolic, intermediate, and central. 
If the central lymph nodes are blocked by the tumour, lymphatic 
flow can become retrograde along the marginal arcade.  The risk for a 
lymph node metastasis increases with an increasing tumour grade. 
 
  
(c) Haematogenous spread 
The liver is the primary site of a haematogenous metastasis, 
followed by the lungs.  A pulmonary metastasis can occur directly in low 
rectal cancers.  Rarely, bone metastases are seen in the disseminated 
disease. 
(d) Implantation 
a. Intraluminal spread:  
Cells from the primary tumour are shed into the lumen during 
manipulation and are implanted at the anastomotic sites, surgically 
treated haemorrhoids, and fistulas. 
b. Peritoneal seedling: 
Tumours infiltrating the serosa can spread transperitoneally to the 
pelvis.  A seedling at the port sites after laparoscopic colonic resection is 
also reported. 
SURGICAL PATHOLOGICAL STAGING 
Duke’s classification 
Stage A Penetration into but not through the bowel wall. 
Stage B Penetration through the bowel wall. 
Stage C Any tumour with involvement of lymph nodes. 
 
 
 
  
TNM CLASSIFICATION (THE UICC AND THE AJCC STAGING 
SYSTEM) 
T-Primary tumour 
 Tis Carcinoma in situ 
 T1 Tumour invades the submucosa 
 T2 Tumour invades the muscularis 
 T3  Tumour invades through the muscularis propria into the  
subserosa or into nonpreitonealised  pericolic, or perirectal 
tissues. 
 T4 Tumour perforates the visceral peritoneum or directly  
invades other organs or structures. 
N-Regional lymph nodes 
 NX Regional lymph nodes cannot be assessed 
 NO No regional lymph node metastasis 
 N1 Metastasis in 1 to 3 pericolic or perirectal lymph nodes 
 N2 Metastasis in 4 or more pericolic or perirectal lymph nodes 
 N3 Metastasis in any central lymph node (along the course of a  
named vascular tree) 
 
 
 
 
  
TNM    Duke’s Classification 
Stage 0 Tis NO MO  
T1 NO MO  
Stage I 
T2 NO MO A 
T3 NO MO  
Stage II 
T4 NO MO B 
Any T N1, MO  
Stage III 
Any T N2, N3 MO C 
Stage IV Any T Any N M1  
 
Additional prognostic variable 
Factors associated with less favourable prognosis  
Clinical features 
• Age – less than 40 years 
• Males 
• Symptomatic patients 
• Obstruction and perforation 
• Location – rectosigmoid and rectum 
Pathological features 
• Adjacent organ involvement 
• Positive lateral margins on histopathological examination 
• Grade 3 tumour (poorly differentiated) 
• Mucinous cancer 
• Lymph vessel invasion 
• Perineural invasion 
  
Other features 
• Preoperative CEA levels reflect the tumour burden 
• Aneuploidy is a poor prognosis factor 
POLYPS IN COLON AND RECTUM 
Type of Polyps Features Risk of Malignancy 
Adenomatous 
Polyps           
    - Tubular 
4 times more frequent, 
smaller in size, 
distributed throughout 
colon 
Risk – 2 times 
    - Villous 
Larger in size, usually 
solitary, involves 
rectum and distal 
colon 
Risk – 8 times 
Hamartomatous 
polyps 
Peutz-Jeghers and 
juvenile polyposis Low risk 
Inflammatory polyps Ulcerative colitis (pseudopolyps) Low risk 
 
MANAGEMENT OF POLYPS 
a) Pedunculated polyps – endoscopic polypectomy by snare 
technique. 
b) Sessile lesions – can be removed piecemeal and large sessile 
villous lesions may require colectomy for safe removal. 
c) Large, flat, villous adenoma of the rectum is a challenging 
problem: 
About 75 per cent of soft, non-ulcerated tumours are benign on 
histology, whereas 15 per cent contain superficial cancer, and only 
10 per cent contain invasive cancer. 
Transanal local excision up to the submucosa is recommended 
followed by HPE. 
  
d) In very large tumours: full-thickness excision by a posterior 
approach is done. 
Anterior resection or colonic resection may be necessary. 
Familial adenomatous polyposis 
 Restorative proctocolectomy with a distal mucosal proctectomy 
and an ileal J-pouch-anal anastomosis are recommended in patients 
before the second decade. 
 A total proctocolectomy with a permanent ileostomy is done if the 
rectum has a carcinoma. 
Ulcerative colitis 
 Restorative total proctocolectomy with ileal pouch-anal 
anastomosis should be considered in younger patients undergoing 
elective surgery; total proctocolectomy with permanent ileostomy is 
recommended in the elderly and in complicated colitis. 
TREATMENT OF COLON CANCER 
Surgery with curative intent 
Pre-treatment evaluation 
History  
 In addition to the personal medical history, the family history of 
colorectal cancer, polyps, and other cancers should be noted. 
 
 
  
Physical examination 
 This is done especially for hepatomegaly, ascites, 
lymphadenopathy, asynchronous breast or ovarian cancer. 
Laboratory data 
Blood count, liver chemistry (alkaline phosphatase) are done. 
CEA 
Oncofetal antigen. Nonspecific. Elevated in so many other 
conditions. Benign elevation upto 2-5 ng/dl seen. Other tumor markers – 
Ca19-9, Ca50 Lewis blood group Antigen. They are not of proven value.  
CEA is useful only in post op. follow-up. Not diagnostic. Screening 
preoperative value > 45ng/dl suggests advanced lesion. Raising 
postoperative titres are useful. Combined with imaging. 90% accurate in 
predicting recurrence. ↑CEA in the absence of disease by imaging 
suggests liver metastasis. 
Gastrointestinal 
1. BARIUM ENEMA: 
Gives idea about Lie of the colon, Redundancy of loop, Total 
colonic length, Rectosigmoid length and Diverticulosis. They help in 
planning colonoscopy. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COLONOSCOPE 
 
 
 
 
 
 
 
 
 
 
 
 
     CAECUM   TRANSVERSE        DESCENDING 
     COLON   COLON 
 
 
 
 
 
 
 
 
 
 
 
         PROLIFERATIVE   POLYP 
  GROWTH 
 
 
COLONOSCOPIC VIEW 
 
 
  
2. COLONOSCOPY 
Gold standard investigation nowadays. New generation Scopes  
with video monitoring available. 
Advantages     
Direct visualization, color appreciation, Nature of lesion can be 
seen and Biopsy can be taken. 
Complications: 
Perforation - 1in 5000 – 10000 cases, Bleeding following 
procedures, Bacterimia, and procedure cannot be completed in some cases. 
Disadvantages:  
 Error of localization in long redundant loop, Extracolonic 
pathology not appreciated, High Cost, Less availability, Need for 
sedation during procedure. 
Preparation for both colonoscopy & DCBE  
Ideally 48hrs preparation in our setup. Day 2 - Liquid diet,        
Day 1 - Clear fluids Peglec 4-6pm.  Starvation after 9pm.  Enema at 
9pm.  Day 0 - Enema 4hrs prior to procedure. Iron formulations to be 
avoided for 5 - 7 days before colonoscopy. 
Double-contrast barium enema  
Traditional method, 70-100 w/v Ba.Sulphate used. 100kV machine 
necessary for good exposure. Fluoroscopic guidance is essential. Good 
preparation must. Tumour manifests as filling defect, Apple core 
appearance Contour defect, Stricture and Intussusceptions. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DOUBLE CONTRAST BARIUM ENEMA  ENDORECTAL  
ULTRASOUND 
 
 
 
 
 
 
 
 
 
 
 
 
  
Advantages 
Entire colon is visible. Accurate location of lesion possible. 90% 
sensitive for lesion more than 1cm. Cost effective. no technical expertise 
needed. Patient Compliance good. Minimal complications. Extra colonic 
compression, fistula made out well. 
Disadvantages 
Biopsy not possible. Less sensitive for lesion < 1cm. Difficulty in 
identifying lesion in the Flexures and in sigmoid colon with 
diverticulosis. 
Imaging 
 Preoperative chest radiography should be done. 
USG / CT Scan  
USG    
USG indicated if there is 
a) High CEA,  
b) Abnormal liver chemistry, 
c) Borderline resectability, and 
d) Associated medical illness. 
 
It gives idea about origin and location of mass, Bowel mass – 
pseudokidney appearance, Liver involvement, Nodal involvement and 
Ascites Intraoperative USG very sensitive for liver metastasis, 
Hydrocolonosonography - ↑ pick up of bowel lesion. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VIRTUAL COLONOSCOPY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CT SCAN SHOWING LIVER SECONDARIES  BARIUM ENEMA 
               ASCENDING COLON GROWTH 
  
Endoscopic ultrasonography 
 
 
Endorectal USG - best study in distal 12cm of rectum. High 
frequency probe with 10MHz is used. Tumor staging very accurate.      
T2 - T3 differentiation is more accurate. Nodal pickup rate is 59%.  
 
CT Abdomen 
 
Important tool in preoperative assessment. Both oral &IV contrast 
given. Bowel wall thickness > 4mm suggests malignant Lesion. Mass 
lesions, Renal function and ureter involvement made out well. 
 
 
MRI 
 
 
Done when indeterminate liver lesions on CT found and in Rectal 
for lesions. Endorectal pelvic coil improves pick up rate, helps in 
accurate tumor staging 
 
CT Colonoscopy (virtual colonoscopy)  
 
 
CT images reconstructed with 3D software. Needs CT in supine 
and sitting posture. Both colonoscopic and DCBE view can be reconstructed. 
Still in developmental stage. Needs same preparation as colonoscopy. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTESTINAL OBSTRUCTION – DILATED BOWEL LOOPS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
TREATMENT 
General surgical principles 
 The morbidity of elective colon surgery is directly related to the 
mechanical and oral antibiotic bowel preparation, the use of 
perioperative systemic antibiotics, and the skill of the surgical and 
anaesthesia team. 
 En bloc surgical resection is the primary treatment in patients with 
colon cancer. 
 
Extent of lymph node dissection 
 Surgical treatment of colon cancer requires excision of an 
adequate amount of the normal colon with removal of intermediate and 
central lymph nodes requiring ligation and division of multiple, main 
vascular trunks.  The lymphadenectomy is not only necessary for 
staging, but is also therapeutic. 
 Prevention of an intraluminal spread can be achieved by the 
irrigation of the lumen with water, 5-FU, and povidone iodine. 
 
Prophylactic oophorectomy 
 The ovaries should be removed, if found to be grossly abnormal 
and in all postmenopausal women. 
 
 
  
Specific Management Problems in Colon Cancer 
Synchronous cancers 
 Synchronous colorectal cancer occurs in 3 to 5 per cent of 
patients. 
 Preoperative examination of the remaining colon is recommended, 
either by air-contrast barium enema or preferably by colonoscopy. 
Obstructing cancers 
 Left-sided colon obstruction was managed traditionally by the 
following procedures. 
Three-stage operative approach 
1. Diverting transverse colostomy 
2. Tumour resection 10 to 14 days later 
3. Closure of colostomy 
Two-stage Hartmann procedure 
 The tumour is resected, with the proximal colon brought to the 
skin as an end-colostomy.  The distal colon is closed by sutures or 
staples. 
 The second operation re-establishes intestinal continuity. 
 Intraoperative whole-gut colon lavage may be used to clear the 
colon proximal to an obstruction.  This may allow an on-stage resection. 
However, the faecal masses are solid, and it is safer to do a transverse 
colostomy if the colon is loaded. 
 
  
 
 
 
 
 
 
 
 
 
SPLENIC FLEXURE GROWTH  
 
 
 
 
 
 
 
 
 
SPLENIC FLEXURE GROWTH (CUT SPECIMEN) 
 
 
  
 It is important at the time of initial surgery to examine the caecum 
for perforation and the liver for metastases. 
 The patient with an obstructive cancer of the ascending colon can 
usually be treated with single-stage resection.  An ileocolic anastomosis 
is performed, which even in the absence of bowel preparation usually 
heals without complications. 
Perforating cancers 
 Perforation of the colon can occur proximal to an obstructive 
cancer.  An early diagnosis and intervention with surgical resection / 
colostomy, peritoneal cavity irrigation, drainage, and antibiotic 
administration are necessary to salvage the patients. 
Contiguous organ involvement 
 Direct involvement of adjacent organs occurs in about 10 per cent 
of patients.  Extended surgery in such patients has cure rates of 20 – 50 
per cent.  The tumour – bearing colon may be adherent due to 
inflammatory adhesions in about half or it may be attached by direct 
penetration of the tumour.  All such attachments should be presumed to 
be due to direct tumour penetration and should not be divided, but 
biopsied.  Penetration into an adjacent hollow organ, such as the bladder 
or small bowel, may lead to a fistula.  Posterior exenteration is 
recommended in females with involvement of the uterus.   However, 
total exenteration in males would be recommended in only a small 
percentage of patients without any evidence of nodal or visceral 
metastases.  Managing a colostomy and an ileal conduit can be difficult. 
  
TREATMENT OPTION IN SPECIAL OCCASIONS 
Cancer in polyps 
 Cancer is present in about 5 per cent of the adenomatous polyps. 
Patients at high risk for developing local residual or nodal 
metastatic cancer are: 
1. Poorly differentiated cancer 
2. Lymphatic vessel invasion 
3. Tumour invading the pedicle 
4. Positive or close polypectomy margin 
Polypectomy alone is sufficient in almost all patients with a 
moderately or well-differentiated cancer, limited to the head of a 
pedunculated adenomatous polyp, with clear margins on the stalk, and 
no histopathologic evidence of a lymphatic vessel invasion. 
The polypectomy site should be examined endoscopically in 4 to 6 
months to confirm the absence of mucosal recurrence.  Not all polyps 
can be removed endoscopically.  Large sessile lesions, particularly of the 
thin-walled ascending colon, pose a major therapeutic challenge.  Large 
villous tumours have a high likelihood (upto 40 percent) of containing 
the carcinoma in the polyp. 
 
 
 
  
Surgery 
 In analyzing the data about the usefulness of CEA directed 
second-look surgery, several issues are important. 
Sites most amenable to curative resection 
 Selected liver and lung metastases and some locally recurrent 
cancer may be resected for a cure in a selected group of patients.  Other 
sites like para-aortic nodes cannot be resected for a cure even if 
localized. 
Negative exploration 
About 90 per cent of the patients selected for a second-look 
surgery have a recurrent tumour.  Most patients, in whom surgical 
exploration is negative, will ultimately develop clinical signs of recurrent 
cancer in due course. 
Surgical resections 
 Resectability is variable (27-65 percent) depending on the 
frequency of the follow-up. 
Cures  
 Despite considerable variability in long-term survival data, about 
30 per cent of the patients who undergo second-look operation and 
resection, based on CEA assay results, are alive and free of cancer at 5 
years. 
 
  
Cost 
 The cost of a CEA follow-up programme is substantial when the 
expenses of the assays, additional laboratory tests, scans, and surgery are 
included. 
Overall impact on survival 
 It is likely that surgery, based on clinical criteria or on a CEA 
blood test, can improve overall survival only by 5 per cent (3 and 2 per 
cent respectively) of the entire patient population undergoing potentially 
curative resection of colorectal cancer. 
TREATMENT OF RECURRENT OR METASTATIC CANCER 
Metastatic colorectal cancer 
Liver metastases 
a) Indications for surgery 
a. Absence of extrahepatic disease 
b. Solitary liver metastasis or metastasis confined to one lobe 
c. < 3 metastases in both lobes 
d. Long disease-free interval 
b) Chemotherapy for non-resectable metastases 
Hepatic arterialchemotheraphy: Continuous infusion of 5-FUDR 
or 5-FU by operative cannulation of the hepatic artery using a continuous 
infusion pump is shown to palliate patients with symptomatic liver 
metastases.  This is indicated if the recurrence is confined to the liver. 
Disseminated disease: Chemotherapy with 5-FU and leucovorin 
has marginal benefit in treating such patients. 
  
Symptomatology 
Retal and rectosigmoid cancers are much more likely to be symptomatic 
before the diagnosis. 
• Bleeding per rectum.  
Gross red bleeding (alone or mixed with the stool) is a frequent 
symptom. Haemorrhoidal bleeding should always be a diagnosis 
of exclusion. 
• A change in the bowel activity. 
Large benign sessile adenomas may require surgical resection. 
Results 
Cure rates for node-negative patients 
The 5-year survival rates are as follows: 
T1 NO > 90 per cent 
T2 NO    80 per cent 
T2 NO    60 to 80 per cent 
Cure rates for node-positive patients 
 One to four positive lymph nodes: 56 per cent 
Patterns of Recurrence 
 Dissemination of the disease remains the major risk for recurrence 
in patients with colon cancer.  The liver is involved in as many as two-
thirds of the patients who die of colon cancer.  However, two-thirds of 
the patients with disease recurrence at any site had some component of 
locoregional failures with only 6 per cent of isolated local failure. 
  
Adjuvant Therapy 
 Patients with Stage I disease do not benefit from adjuvant therapy.  
Stage II and III rectal cancer patients have improved local control and 
survival with combined post OP chemo RT. Stage II colon cancer treated 
with adjuvant chemotherapy. RT not used for colon cancer. 
 The most convincing data on adjuvant chemotherapy with 5-FU 
and levamisole come from two recently reported studies.  Combination 
of levamisole and 5-FU resulted in a statistically significant reduction in 
tumour recurrence (disease – free survival of 63 per cent versus 47 per 
cent for surgery only) and improved survival (3-year overall survival of 
71 per cent versus 55 per cent for surgery only).  The estimated 
reduction in death rate for 5-FU + levamisole was 33 per cent compared 
with no further therapy. 
 The National Institute of Health Consensus Development 
Conference in April 1990 recommended that stage C patients be offered 
adjuvant 5-FU and levamisole.  NIH recommendations are: 
Colon cancer: Stage III (positive lymph nodes) 
• Inj.  5-Fu 450 mg/sqm IV daily for 5 days starting 4-6 weeks after 
surgery. 
• Later, Inj. 5-FU 375 mg/sqm weekly IV push with 
• T. Levamisole 150 mg/day for 3 days once in 15 days to be 
continued for 1 year. 
  
Local radiation therapy 
 Adjuvant radiation is recommended only if soft tissue infiltration 
into the psoas or abdominal wall occurs.  The region has to be marked 
with clips intraoperatively so that radiotherapy can be given to a 
localized area. 
Follow-up after potentially curative surgery 
Test Frequency Duration 
History and 
Physical examination 
Every 3 months then 
every 6 months 
For 3 years 
For 2 years 
Faecal occult blood As above As above 
Colonoscopy 6 months after surgery and later once a year 3 years 
Alkaline phosphatase 3 months 3 years 
CEA 
(carcinoembryonic 
antigen) 
Every 3 months For 3 years 
Sigmoidoscopy  
(in rectal cancer) 
Every 6 months or 
earlier, it symptomatic For 5 years 
Chest X-ray Yearly 5 years 
USG / CT scans 
If symptomatic / 
investigations 
abnormal 
 
 
Locally unresectable colon cancer 
 Tumours may be unresectable even if there is not distant 
metastasis.  Extensive direct extension into the retroeritoneum, pelvic 
sidewall, or duodenum, or pancreas may be found.  In the presence of 
concomitant metastatic disease, a bypass enteroenterostomy is usually 
appropriate.  In the absence of distant disease in otherwise healthy 
patients, an aggressive local surgical approach should be undertaken 
(Palliative resection). 
  
Treatment on the basis of serial CEA assay 
 Postoperative serial serum carcinoembryonic antigen levels may 
be elevated in an asymtomatic patient. Transient CEA elevations can 
occur and an increasing trend is more significant. 
 Asymptomatic patients with raised CEA may fall into one of the 
three groups: 
1. A new primary cancer 
2. A recurrent colorectal cancer 
3. No detectable disease on imaging and evaluation.  Options in 
managing these patients include continued observation, repeated 
examinations and tests, chemotherapy, and surgical exploration 
(second-look surgery) 
• Unexplained constipation 
• Spurious diarrhoea (due to obstructing rectal cancers) 
• Urgency and inadequate emptying 
• Tenesmus (indicates transmural penetration) 
• Urinary symptoms (may occur with compression of the bladder 
and invasion of the prostrate) 
• Buttock or perineal pain (from posterior extension) 
All patients with rectal symptom, particularly bleeding should be 
evaluated by sigmoidoscopy, preferably fibre-optic up to 60 - 63 cm. 
 
 
 
  
RECTAL CANCER 
Special investigations 
Intrarectal ultrasound 
Intrarectal (IRUS) or transrectal ultrasound is excellent in 
detecting the degree of primary tumour penetration, and fair to good in 
detecting lymph node metastass. 
Surgical Management 
The following issues need clarification 
1. Distal mucosal margin 
Sphincter-saving surgery for patients with distal rectal cancer 
requires an ‘adequate distal margin’.   A 3cm distal margin is adequate 
as only 2.5 per cent of patients demonstrate disease spread more than 
2cm. The few patients with extensive distal spread usually have poorly 
differentiated, node-positive rectal cancers that disseminate rapidly.  
There is no correlation between the risks of suture-line or local 
recurrences and the extent of a distal margin more than 2 cm.  As there is 
stretching during surgery, a surgical margin of 3 cm is recommended. In 
bulky, poorly differentiated tumours, abdominoperineal resection is a 
better alternative. 
 
 
 
  
2. Extent of proximal lymph node dissection 
 
In patients with rectal cancer, the measorectum should be removed 
at least to the level of the aortic bifurcation.  This includes all nodes just 
distal to the origin of the left colic artery, but not the periaortic nodes or 
close along the inferior mesenteric artery. 
 
3. Distal lateral extent of pelvic dissection 
 
No survival advantage could be demonstrated with extended 
abdominopelvic nodal dissection. To maximize the lateral margins, 
pelvic surgery should be performed by sharp dissection outside the 
mesorectum on the endoplelvic fascia.  This can be done while sparing 
the pelvic nerve plexus by doing nerve-sparing pelvic sidewall 
dissection.  Although a 2 to 3cm distal mucosal margin is usually 
adequate, local control of rectal cancer requires maximum extirpation of 
mesorectal and lateral pararectal tissues. 
Site-specific treatment options  
Upper rectum (>11 cm) 
• Anterior resection – hand sutured or stapled 
• Adjacent organ resection (e.g., partial cystectomy, small bowel 
resection) is justified to achieve local control 
 
  
Mid rectum (6 – 11 cm) 
1. Low anterior resection (most frequent) 
- Stapled or hand-sutured 
2. Coloanal anastomosis 
- Pull through or stapled 
3. Abdominosacral approach 
Factors influencing patient selection 
1. Age : Sphincter tone should be adequate, particularly after  
65 year of age. 
2. Sex : Gynaecoid pelvis is roomier and facilitates low  
anastomosis. 
3. Build  : Obesity and narrow pelvis limit surgical access. 
4. Grade : Gr.III tumours have higher chances of local  
recurrence and abdominoperinecal resection is 
preferred. 
5. Pararectal : Large bulky tumors with extensive pararectal spread                         
        are not suitable for conservation.  
Low rectum (<6 cm) 
 About 95 per cent of low rectal cancers in India can be offered 
only abdominoperineal resection.  A small group of patients may be 
considered for local treatment options. 
 
  
 
 
 
 
 
 
 
 
CA RECTUM  
 
 
 
 
 
 
 
 
 
CA RECTUM (CUT SPECIMEN) 
 
 
 
  
Selection criteria: 
1. Medical contraindications to radical surgery. 
2. Polypoid, exophytic lesion 
3. <3 cm in size 
4. Low-grade malignancy 
5. Limited to submucosa 
The local treatment options are  
(A) Surgery: 
1. Posterior proctotomy (Kraske’s approach) 
2. Trans-sphineteric (York-Manson approach) 
3. Transanal excicison (limited role) 
(B) Radiotherapy 
1. Endocavitary radiation (Papillion technique) 
2. External RT is widely employed in patients with bulky fixed 
lesions that do not seems to be resectable.  After RT some lesions 
can be removed. 
(C) Palliation 
1. Fulguration 
2. Nd-YAG laser 
3. Cryotherapy 
 
 
  
 
 
 
 
 
 
 
 
 
PELVIS AFTER APER 
 
 
 
 
 
 
 
 
 
 
 
 
  
Preoperative bowel preparation for colorectal surgery  
1. Low residue diet (clear liquids) for 3 days. 
2. Laxative (milk of magnesia) for 3 days. 
3. Bowel wash twice a day for 2 days, but no enema on the day of 
surgery. 
4. Luminal antibacterials-Metronidazole (400 mgs t.d.s. orally) for 
3days 
5. Parenteral antibiotics – Inj. Cephalosporin and gentamicin along 
with premedication. 
Mechanical preparation is the single most important factor.  Oral 
mannitol can be used if there no obstruction. 
Surgical procedures  
Abdominoperineal resection 
 Abdominoperineal resection is done as a synchronous 
transabdominal and perinal procedure with two operative teams 
Position: Modified lithotomy position 
Technical points:  The locoregional and distant spreads are evaluated 
and mobility of the lesion assessed. 
 The lateral peritoneum is incised an the sigmoid mobilized, 
identifying the ureter. 
The inferior mesenteric artery is ligated below the left colic after 
peritoneum on both side of the mesorectum 
  
Posterior mobilization is done carefully preserving the presacral 
nerves and without breaching the presacral fascia.   Damage to the 
presacral fascia can lead to severe haemorrhage from the presacral veins. 
The anterior plane is just behind the seminal vesicles. 
And end-sigmoid colostomy is brought out through the rectus 
sheath to minimize subsequent hernia. 
The small bowel should be excluded from the pelvis. 
The pelvic fat and skin can be closed primarily.   
The role of the enterostomal team is most vital for proper 
rehabilitation of an ostomate. 
Low anterior resection 
 If transanal reconstruction with a stapler is being planned, the 
patient is positioned in the modified lithotomy position. The initial stages 
of the operation with complete mobilization of the rectum to the level of 
the levators are identical to those of the abdominoperical resection. The 
anastomosis can be done by hand suturing in a single layer or by using a 
stapler.  An intraluminal circular stapler placed by a transanal approach 
allows a very low anastomosis in the pelvis. 
 Temporary protective transverse colostomy is done if the colon is 
unprepared or if the anastomosis is not satisfactory (incomplete 
doughnuts). 
 
 
  
Coloanal anastomosis 
 After complete mobilisation and resection of the rectum from an 
abdominal approach, the bowel continuity is restored by bringing the 
colon to the level of the anus and dentate line and using a local surgical 
anastomotic technique. 
Local surgical resection 
 If the lesion is too large for transanal local excision, two other 
surgical approach are available; 
a) Posterior proctotomy (Kraske’s approach): 
 In this, a perineal incision is made just above the anus, the coccyx 
is removed, and the fascia is divided.  The rectum is mobilized, and a 
wide local excision or a sleeve resection can be performed. 
b) Transsphincteric procedure (Yark-Mason approach): 
 The transphincteric approach is identical to the posterior 
proctectomy, except that the entire anal sphincter is divided posteriorly 
in the midline.  Each position of the sphincter mechanism is identified 
and marked, the aim is to reconstruct the sphincter at the completion of 
the operation with the least risk of a functional impartment. 
 
 
 
 
  
Morbidity 
(1) Neurogenic bladder 
Catheter drainage of the bladder is used for 7 to 10 days, after 
which most patients can void spontaneously. Obstructive cause 
like prostatic hypertrophy has to be excluded.  Bethanechol 
chloride may be useful in improving the bladder tone.  Intermittent 
catheterisation may be necessary in some patients 
(2) Sexual dysfunction 
Retrograde ejaculation results from the loss of sympathetics.  
Erectile impotency results from damage to the pelvic parasympathetic 
plexus. 
     (3) An association of Perioperative blood transfusion with increased 
IL-6 levels and poorer prognosis in colorectal cancer has been found by 
some but not all the investigators. 
Postoperative radiation therapy (Adjuvant radiation therapy) 
 For the past decade, the primary focus of clinical research in the 
adjuvant treatment of resectable rectal cancer has involved the use of 
postoperative irradiation and chemotherapy.  Postoperative radiation 
therapy to the pelvis with chemotherapy in the first and last weeks of 
radiation is recommended for tumours infiltrating the full thickness of 
the rectal wall with / without nodal involvement. (Dukes B2 and C2) 
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MATERIALS AND METHODS 
Period of study  – November 2004 – September 2006. 
Observation study on cases with colorectal 
carcinoma. 
Number of cases taken for the study: 37 
Materials 
I. Clinical evaluation 
a. Age incidence 
b. Sex incidence  
c. Presenting features 
1. Pain, 2. Mass, 3. Obstruction,  4. Bleeding 
5. Anemia. 
d. Time of presentation 
e. Clinical examination. 
II. General condition of the patient evaluated.  Presence of 
features like anemia, lymphadenopathy, pallor, Jaundice were 
noted. 
Examination of the cardiovascular, respiratory and skeletal 
system to find out metastasis was done. Thorough examination 
of the abdomen looking for distention, obstruction features, 
  
mass, Ascitis were done.  Per rectal examination to diagnose 
ano-rectal growth, obstruction and pelvic deposits were done. 
Investigations 
a. Hemoglobin estimation  b. Chest X-ray 
c. Plain X-ray Abdomen  d. serum potassium, e. LFT. 
f. USG Abdomen  g. Barium enema 
h. Colonoscopy / Sigmoidoscopy  
i. CT Scan abdomen in selected cases. j. Biopsy 
Treatment 
 Based on the investigation and clinical findings patients were 
taken up for the following modalities of treatment 
1. Curative surgery. 
2. Palliative surgery 
3. Chemoradition   
4. Combination of surgery and chemotherapy. 
5. Surgery chemo and RT 
6. Preop RT Æ Surgery 
 Type of surgery performed varied from definitive colostomies, 
staged procedure in which initially Hartman’s procedure was carried out 
and Later definitive surgery was performed and APR, Intra operatively 
the patients were examined for site of growth, serosal involvement, liver 
and peritoneal involvement and free fluid. Pre op and post op chemo 
radiation were given in selected cases.  Bowel preparation with peg leg 
  
and soap and water enema was done in all the cases presenting without 
obstruction pre op antibiotics were given. 
 Patients were monitored in the post operative period and treated 
with 1v fluids, analgesics and antibiotics.  All the patients who 
underwent extensive surgery in whom severe pain is expected were 
provided analgesia through epidural route for 2 days when prolonged 
immobilisation is anticipated injection heparin 5000 units given 
subcutaneously for 5 days and all the patients were encouraged to walk 
from the 3rd postoperative day to prevent deep vein thrombosis and 
complications noted.   
Follow up: 
 All the patients were followed up for a mean period of 6 months 
most of them as out patients few of them as inpatients.  During the 
follow up the patients were carefully examined for presence of metastatic 
features thorough history physical examination and investigations like 
chest x-ray, fecal occult blood testing, CEA, ultra sound and CT scan 
were done according to the time of presentation and symptomatology. 
 All the information collected was pooled and master chart 
prepared, from which analysis of the disease was done and conclusion 
arrived. 
Adjuvant therapy: 
  
 Adjuvant chemo RT started after 3 weeks of surgery. 
chemotherapy was given with 5 fu and cisplatin.  Radio therapy is given 
in the form of external beam RT. 
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OBSERVATIONS AND RESULTS 
Age group 
 
 
 
Age group No. of Patients Percentage 
10 – 20 1 2 
20 – 30 4 11 
30 – 40 8 22 
40 – 50 9 24 
50 – 60 5 13 
60 – 70 8 22 
70 – 80 2 5 
Total 37 100 
 
 
 
Majority (46%) of cases presented at the age of 30 – 50.  Next peak 
occurring in 60 – 70 age group which comprises of 22%.  No patient was 
< 19 years old or > 76 years old.  13% of cases occurred in II and III 
decades of life. 
 
 

  
SEX INCIDENCE
41%
59%
MALE FEMALE
  
Sex incidence 
 
 
 
Sex No. of Patients Percentage
Female 22 59% 
Male 15 41% 
 
 
 15 out of 37 patients were females which accounted for 59%.  
41% were males (M: F :: 2:3). Higher incidence of colorectal ca in 
females may be attributed to genetic or dietary habits. 
 
Diatery habits: 
 Over 90% of patients were non-vegetarians.  Predominately they 
consume rice, consume non vegetarian diet once or twice in a week.  
Majority of them chew betel leaves with calcium which is protective for 
colorectal cancer. 
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Mode of Presentation: 
 
Mode No. of patients Percentage 
Pain 29 78% 
Mass 8 21% 
Obstruction 13 35% 
Ascites 8 21% 
Liver Secondaries 10 27% 
Anemia 13 35% 
 
 PAIN is the most common mode of presentation in this group of 
patients.  35% of the patients presented with the obstruction followed by 
21% each with mass and Ascites.  Pain may be tenesmus in rectal 
carcinoma and colicky pain in intestinal obstruction and 1 patient 
presented with neuralgic pain due to involvement of lumbar plexus.  4 
patients presented with dysuria due to bladder involvement. 
 
 27% of the patients were terminally ill with liver secondaries.  
35% of the patients presented with pallor with Hb% < 9gms occurring 
due to generalised debility or bleeding per rectum. 
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Site of Tumour 
 
Site No. of Patients Percentage 
Ascending colon 4 11% 
Descending colon 2 5% 
Hepatic flexure 2 5% 
Splenic flexure 1 2% 
Transverse colon 1 2% 
Sigmoid colon 1 2% 
Proximal rectum 1 
Middle rectum 5 
Distal rectum 15 
73% 
 
 
 Carcinoma is particularly common in the distal rectum.  Again 
there is a significant number of (16) cases in Ascending and Hepatic 
flexure.  
 
 
 
  
INVOLVEMENT OF SURROUNDING STRUCTURES
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Involvement of surrounding structures 
 
 
Organ No. of patients Percentage
Bladder 7 18% 
Vagina 1 2% 
Others – Omentum, Mesentry, Small Bowel  5 7% 
 
 
 Involvement of surrounding organs was seen in 27% of cases. 
 
 In 7 out of 37 there was involvement of posterior wall of bladder 
only in 1 case posterior vaginal wall was involved Omentum, Mesentery, 
Small Bowel were involved, in 5 other cases. growth and infiltration is 
more common in the anterior wall of rectum than in the posterior wall.  
Out of 7, 3 presented with hydrouretero nephrosis. 
 
 
 
 
 
 
  
 
Duke’s Stage 
 
 
Duke No. of patients Percentage 
Duke A 1 3.3% 
Duke B 9 30.7% 
Duke C 20 66% 
 
 
 66% of patient presented with Dukes stage C only, 1 patient was 
detected in Duke stage A, 9 patients were detected in Duke Stage B. 
 
 Indicating fairly late presentation to the hospital for which only 
palliative treatment is possible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
INVESTIGATIONS 
1. Barium enema was done in 19 cases findings correlated with 
other findings in all the cases.  Indicating a high degree of 
sensitivity and specificity.  
2. Serum potassium was done in 25 cases, all the cases showed 
values within normal range. 
3. Blood grouping was done in all 37 cases which revealed 32.4% of 
the patients with blood group ‘O’ and A, B and AB group account 
for 21.6%, 29.7% and 16.2% respectively. 
4. PR Examination was done in 36 cases and it is highly sensitive in 
detecting rectal growth in our series. 
5. Chest X-ray taken for all the patients except one.  It revealed lung 
secondaries in one patient and pleural effusion in 4 patients.  One 
patient showed increased bronchovascular markings. It was 
normal in rest of the patients. 
6. Colonoscopy / Sigmoidoscopy was done in 22 patients all yielded 
positive results and biopsies were taken. 
7. Liver function test was done in 11 cases in whom liver 
involvement was suspected and was found to be deranged in 4 
patients. 
8. Since most of the patients presented with clinically (or) 
Radiologicaly dedectable tumour mass faecal occult blood test 
was not done routinely. 
 
 
  
 
 
TYPES OF CARCINOMA
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Type of Carcinoma 
 
 
Type No. of patients Percentage 
Moderately differentiated Adeno 
carcinoma 18 51% 
Poorly differentiated adeno 
carcinoma 5 14% 
Well differentiated adeno 
carcinoma 7 20% 
Amelanotic melanoma 2 5% 
Others 3 8% 
 
 
 
 
More than 51% of cases were moderately differentiated 
adenocarcinoma.  14% of poorly differentiated and 20% of well 
differentiated adenocarcinoma were present. 2 cases were reported as 
amelanotic melanoma.  2 were squamous cell carcinoma and 1 signet cell 
carcinoma were reported. 
 
 
 
 
  
Type of Surgery tabulation for the study group 
 
 
Elective 15 60% 
Emergency 10 40% 
 
 
 
 60% of cases were taken as elective cases with bowel preparation 
and 40% of cases was taken as emergency surgery.  In the elective cases 
complications like post op wound infection, obstruction or retraction of 
colostomy was present in only 12% of cases.  Where as in emergency 
cases 16% of cases had above complications.  The outcome was almost 
identical after the immediate post op period in both the groups. 
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Type of Treatment given: 
 
Treatment No. of patients Percentage 
Colostomy 7 19% 
APER 11 30% 
Hemicolectomy 6 16% 
Symptomatic 2 5% 
Curative chemo RT 14 38% 
Palliative Chemo RT 9 24% 
 
 30% patients underwent APR. 19 patient underwent colostomy 
most of which were sigmoid loop colostomy.  4 patient with APR and 3 
patients each with colostomy and hemi colectomy underwent pre or post 
op chemo radiation therapy.  Neo adjuvant chemo RT was given for 11 
cases 3 cases received post op chemo RT.  9 patients were given 
palliative chemo RT. 
  
Radiotherapy is given in the form of external beam RT in a dose 
of 35 – 40Gy in divided doses over 1 month period.  6 cycles of 
chemotherapy is given with cisplatin (100 – 200mg/m2/dose IV every 3 
to 4 weeks) and 5 FU (600mg/m2/IV 1st and 8th day). 
 
  
Complications: 
 
 
Complications Number Percentage 
Wound infection 3 12 
Obstruction 1 4 
Delayed wound healing 1 4 
Bleeding from colostomy 1 4 
Prolonged ileus 1 4 
Others 1 4 
Total 8 32 
 
 
Out of 25 cases operated 8 patients developed complications, out 
of which 12 % of cases developed wound infection for whom daily 
dressing and secondary suturing done.  One patient developed 
obstructive features which got releived on giving enema through 
colostomy.  Delayed wound healing, bleeding from colostomy and 
prolonged ileus were other complications noted which got corrected with 
conservative management. 
 
 
 
  
Follow up 
 Out of 37 patients who underwent treatment.  26 patients came for 
follow up.  During the follow up patients were examined with careful 
history and physical examination pertaining to detecting metastasis or 
local recurrence.  Patients were subjected to faecal occult blood testing, 
Chest X-ray, Colonoscopy, LFT, ultra sound and CT depending upon the 
symptoms and duration after surgery.  CEA analysis was not done 
routinely in the follow up period since the patients were not affordable 
for the investigation. 
2 patient developed local recurrence for whom USG at 3 months 
revealed normal study and 6 months showed multiple pelvic deposits 
with liver involvement. Findings were confirmed with CT scan and they 
received palliative radiotherapy, 1 had mild retraction of the colostomy 
but functioning well. 
 1 patient had infiltration in the lumbo sacral plexus with severe 
neuralgicpain for whom palliative chemo RT given.  For this patient 
chest X-ray was normal and CT scan of pelvis showed infiltration into 
the sacrum and surrounding structures. 1 patient with rectal carcinoma 
presented with massive acitis and pleural effusion for whom examination 
revealed lung secondaries and liver secondaries findings were confirmed 
with Chest X-ray CT abdomen and thorax and LFT and was managed 
symptomatically.   
  
2 patients presented with subacute obstruction which got relieved 
by enema.  Colonoscopy through colostomy was done for these patients 
which was normal study. Rest of the patients were asymptomatic during 
the follow up period. 
Total no. of patients 26 
Asymptomatic 15 
Local recurrance 3 
Dissemination 1 
Sub acute obstruction 2 
Pelvic pain 5 
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DISCUSSION 
 
In Thanjavur Medical College colorectal carcinoma accounts for   
2.5% of all the cancer cases. 
Age incidence of colorectal carcinoma 
 
Number of Cases 
Goligher et al 
Our study Age 
group 
Number % Number % 
20 – 29 25 2 4 10.8 
30 – 39 63 5 9 24.3 
40 – 49 145 12 9 24.3 
50 – 59 351 
58
4 
< 
60
 
30 
49 
5 13.5 
72.9
60 – 69 443 37.8 8 21.6 
70 – 79 139 11.8 2 5 
26.1
80 – 89 5 5
87
 >
 6
0 
4 
51 
   
  1171   37   
 
 Colorectal carcinoma affects predominantly younger age group 
patients than the older ones compared with the western population.  In 
this study 72.9% of patients were less than 60 years of age. Goligher et 
al reported an incidence of 49%.  Older patient > 60 year account for 
only 26.1% of patients in our study whereas it is 51% in Goligher’s 
study. 
  
 
 This early presentation of colorectal cancer in Thanjavur 
population may be postulated as due to, 
1. Younger individuals makeup the bulk of population in Indian 
region.  In western world older individuals make up a substantial 
proportion of population according to Parks Text book of 
community medicine. 
2. Older patients unwillingness to take up treatment either due to 
lack of knowledge about the disease, taking native medicine or not 
taking any treatment at all. 
Sex incidence 
Ca rectum 
Mean age of presentation 
Sex 
Dukes (1940) Our study 
Males 58.6 45.4 
Females 55.1 44.7 
 
Dukes (1940) reported that ca rectum presents earlier in females 
(Mean age is 55.1 year) than males (58.6 years).  In our study, mean age 
of presentation in Males was 45.4 and females was 44.7 years indicating 
earlier presentation than western population by a decade and slightly 
higher incidence in males. 
 
 
 
  
 
Location of growth with reference to sex incidence 
 There is difference in behavior of ca colon and rectum in regard to 
sex incidence.  Ebown (1900), Clogy (1908), Frazeer (1938) reported an 
equal incidence of carcinoma colon in males and females.  Goligher et al 
(1941) reported 2:1 occurrence in males and females. 
Part of Bowel Male Female 
 Goligher (1957) Ours  
Goligher 
(1957) Ours  
 No. % No. % No. % No. % 
Rectum 559 61.6 12 70.5 385 52 15 75 
Sigmoid colon 176 19.4 1 5 174 23.6 0 0 
Descending colon 18 1 0 0 27 3 1 5 
Splenic flexure 25 1 0 0 25 3 1 5 
Transverse colon 37 4 1 5 40 5 0 0 
Hepatic flexure 20 1 2 11.7 9 1 0 0 
Ascending colon 24 24 
Caccum 48 
7 1 5 
53 
10.4 3 15 
All sites 907    737    
 
 The incidence of carcinoma in various segments of the colon was 
roughly equal in 2 sexes, but ca rectum occur more frequently in male 
than in females in the ratio of 5:3, according to Smiddy and Goligher. 
Debovis (1900), Closs (1908) and Fraser (1938) also reported almost 
equal incidence in males and females. Goligher 1941 reported a ratio of 
2:1 for ca rectum.  In our study rectal carcinoma is more common in 
  
females than in males in the ratio of 5:3. Colonic carcinoma had almost 
equal incidence in male and females. 
Site of growth  
 
 Fraser 1938 
Smiddy and 
Goligher 1957 
Mcdermot 
et al (1981) Our study 
 No. % No. % No. % No. % 
Caecum and 
Ascending colon 234 26 149 21.2 148 21 4 36.3
         
Hepatic flexure 54 6 29 4 37 5.2 2 18.1
Transverse colon 126 14 77 11 95 13.5 1 9 
Splenic flexure 90 10 50 7 30 4 1 9 
Descending colon 27 3 45 6.5 80 11.3 2 18 
Sigmoid colon 369 41 350 50 313 44.5 1 9 
 900  700  703  11  
 
 Multiple tumour of colorectum found in 98 of 3220 patients an 
incidence of just over 3% (Goligher et al, 1951).  In out study there was 
no multiple lesions.  Carcinoma sigmoid accounts for nearly 1/2 of the 
tumour in all the studies carcinoma caecum and ascending colon account 
for roughly a quarter.  There after in order of frequencies transverse 
colon, splenic flexure, descending colon and hepatic flexure are 
involved.  In our study only 9% of colon growths were from sigmoid 
36.3% from ascending colon and caecum 18% each from hepatic and 
descending colon. 
  
 
 
Carcinoma Rectum 
 
Rectum Dukes (1940) (operable cases) 
Goligher (1941)
(All cases) 
Our study  
(All cases) 
Upper 30.8 36% 1 4% 
Middle 32.6 28.6% 5 21% 
Lower 36.6 35.3 18 75% 
 
 Dukes analysed 1000 operated cases of ca rectum.  Goligher 
(1941) analysed 1096 clinical cases.  In both the studies carcinoma is 
more common in upper and lower 1/3 of rectum.  In our study ca lower 
1/3 is much more common accounting for 75%.  Rosato and Marks 
(1981) reports in a study of 2300 cases during 1939 – 53, 1959 – 77, 
noted a decrease in the incidence of cancer rectum from 50% to 25% 
between 1st and 2nd period and increase in sigmoid cancer from 13.2 to 
32%.  Cancer of right colon increased from 11.9 to 18% in the above 
period. 
 
Rosato and Marler 1981 reports in a study of 2300 cases during 
1939 – 53 and 1959 – 77 noted a decrease in the incidence of cancer 
  
rectum from 50-25% between I and II period and increased is sigmoid 
cancer from 13.2 - 32% in the same period. 
 
 
Colorectal carcinoma with obstruction 
 
No. of obstruction Incidence as of obstruction 
Site No. of growths Goligher 
(1957) 
Our 
study Goligher 
Our 
study
Caeam, 
ascending colon, 
hepatic 
178 50 4 28.6% 25% 
Transverse colon 77 20 1 26.5% 6% 
Splenic flexure, 
descending colon 
& sigmoid 
445 180 2 40.4% 12.5%
Rectum 944 40 9 4.2% 56.5%
 1644 290 16   
 
 
 On the right side since the lumen is wide, contents are liquid, 
obstruction occurs as a late feature when compared to left side lesions.  
40.4% of L. side carcinoma colon presented with obstruction in 
Goligher’s study.  Rectum although is the common site for carcinoma 
accounted for only 4.2% of cases of obstruction in Goligher’s study. In 
  
our study, rectal carcinoma accounted for greater than 50% of 
obstruction followed by ascending colon (23%). Whereas sigmoid colon 
accounted for only 12.5%. 
Treatment in obstructed cases 
 
Go1igher et al, 
1957 Our study Treatment in obstructed 
cases  
No.  % No. % 
Expectant 4 1 3 18.7 
Enema alone 14 6 2 12.5 
Caecostomy 54 23.3 0 0 
Colostomy 19 42.8 4 25 
Resection 47 20.3 7 43.7 
Others 13 5 0 0 
All forms of treatment  231    
 
 More than 2/3 of patients underwent curative resection with 
colostomy.  In both the series 1/3 of patients were managed 
conservatively. 
Grade of the tumour 
Rectal carcinoma Goligher 1941 Our study 
Duke A 6.7% 3.3% 
Duke B 56.7% 30.7% 
Duke C 24.1% 61% 
Colloid ca 12.4% 5% 
 
  
More than 60% of the patients presented with Duke stage C in our 
study where as it is 25% in Goligher’s study.  In both the series early 
presentation in Duke stage A was very less. 
Involvement of surrounding organs 
 In 2/3 of the cases involvement of surrounding organs is purely 
inflammatory and contain no actual growth.  (Goligher 1941, Dukes 
1951).  Only 1/3 of cases had actual growth.  So prognosis is much better 
than expected at the time of operation. 
Follow up 
Burry et al (1967) showed that incidence of further primary cancer 
in the large bowel is 1% on a 10 year follow up and rises to over 3% 
when the follow up is extended to 30 years. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
 
 
 
 
 
  
 
 
 
CONCLUSION 
 
• Majority of cases present in the age group of 30 – 60 years. 
• There is a female predominance of colorectal carcinoma in the 
ratio of  3:2. 
• Most common mode of presentation of colorectal carcinoma is 
pain (78%).  Pallor (35%), Obstruction (35%), mass (21%). 
• 75% of the colorectal carcinoma occurred in the recto sigmoid 
region.  11% of the cases presented with ascending colon growth. 
14% of cases occurred the descending colon, splenic and hepatic 
flexures. 
• 66% of cases presented in the advanced stages Duke stage C for 
whom only palliative treatment was possible. 
• Carcinoma rectum predominately involves the anterior wall and 
bladder than posterior wall. 
• Most of the cases were moderately differentiated adeno carcinoma 
(50%). 2 cases of melanoma and squamous cell carcinoma were 
also reported.   Most of the patients were taken up as elective 
  
surgery. Attendance rate of the patients in the post treatment 
period follow up is only moderate. 
 
 
Suggestions 
 Most of the patients presented in the terminal incurable stages for 
whom only palliative treatment was possible.  
Cancer screening 
As per this study 60% of patients were less than 50years old which 
is quite high compared to the western world so the criteria for screening 
for colorectal carcinoma can be revised according to our area. When 
patients with early symptoms are subjected to screening procedures, 
outcome can be improved.  Since most of the patients fall into 30 – 50 
year category patients with the early symptoms of colorectal carcinoma 
should be taken up for screening procedures more avidly.   
Health education to promote awareness among the patients about 
colorectal cancer pertaining its mode of presentation availability of 
screening procedures, various treatment modalities available and about 
the natural course of the disease can be done. 
Cancer prevention can be done by modifying the diet so that it 
contain more of fibres and less of refined carbohydrates avoidance of use 
  
of tobacco products, avoiding consanguineous marriage and screening 
for relatives of patients with hereditary cancer syndromes. 
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PROFORMA 
Name    I.P. No.   Age:  Sex: 
 
Presenting Features: 
 
Pain 
 
Mass 
 
Bowel Movements 
 
Obstruction 
 
Bleeding PR 
 
Dietary habits 
 
Clinical Examinations: 
 
General Examination 
Anemia 
 
Mass site 
 
Liver 
 
Ascites 
 
Pelvic deposits 
  
 
Investigation: 
 
Blood group 
  
 Hemoglobin 
 
 Serum K+ 
 
 Liver function test 
 
 Carcino Embroyonic Antigen 
 
Faecal occult blood 
 Chest X-ray 
 
 Barium enema 
 
 Colonoscopy / Sigmoidoscopy 
 
 Ultra sound abdomen 
 
Growth Characteristics: 
 
 Site 
 
 Serosal involvement     Fixity 
 
 Adjacent viscera      Peritoneum 
 
 Ascites 
 
 Liver 
 
 Pelvic deposits 
 
 Bowel preparation 
 
 Colostomy 
 
 Anastomosis 
 
  
  
 Histo pathological examination 
 
  
 Chemotherapy / radiotherapy 
 
 
Follow up: 
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growth 
proliferative 6cm 
from AV 
growth in rectum rest 
(N) + 
14 Mani 911764 65 M V + - CN VG   O +     8.6 RIF - - NAD O+ve 4 BVM ND Mass (m) 5x4cm in ascending colon ND 
15 Sethuraman 875379 60 M V CP - CN + - + -  + 
PG 4cm from AV 
completely en circling 
rectum 
B+ve 4.8 
B/L 
Massive 
effusion 2o
lung 
PG              DR 
Rectal growth 
Ascites 2o Liver 
pleural effusion 
nodes ⊕ 
Echo-mim Lv dys 
fn LFT - mild   
16 Palaniammal 872296 34 F NV + 
M
a
s
s
 
(
m
)
 
1
5
 
x
 
8
 
c
m
 
i
n
 
R
I
F
 
VG - O + RIF - A +      PD+ NAD O+ve 3.9 NAD PG              AC 
Mass 15x8 RIF 
nodes ⊕ 
BaE ND        
LFT (N) 
17 Palnivel 888232 28 M V + - CN + - 9.2 - - - Rectal growth 6cm from AV O+ve - NAD UPG          MR 
 thickening of 
rectum + 
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Type of CA Diff 
S
t
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e
 Post OP Period Radio therapy Chemo therapy Follow up 
23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 
9 DC + + Small bowel mesentry - - - D 
(L) Hemi colectomy 
with end to end 
Anastomosis 
SE MD ADC C UL except for delayed wound healing - - 6 months normal 
10 DR + + - - - - D APER El MD ADC B 
wound infection 
wound gaping ⊕ 2o 
suturing done 
1 course given - pelvic recurrance  at 6 months 
11 DR - - - - - Enlarged   D APER EL ADC insitu A UL - - NAD 
12 DR - - - - - - - - - WD ADC C - Palliative RT - severe pelvic pain at 6 months  
13 UR + - - - - - D APER El MD ADC B UL - - NAD 
14 AC + - - - + - - 
® hemi EE I/eo 
Transverse 
Anastomosis 
Em MD ADC B UL - - NAD 
15 DR - - - - - - - Surgery defered due to poor GC - ADC C - 
Palliative chemo 
RT given - 
16 AC - - - - - - - - - PD ADC C - Palliative chemo RT Symptomatic given 
Present with 2o in 
lung and liver with 
Ascites symptomatic 
treatment given 
17 MR + + - - - - D APER EL ADC MD C UL Pre OP RT - NAD 
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USG Abdomen and 
Pelvis 
B
a
r
i
a
m
e
n
e
m
a
 
+
/
-
 
O
t
h
e
r
s
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
18 Periyanayaki 884603 31 F M + - CN - O -     10 - - + (A)    +(PB) 
Growth 7cm from AV 
complete obstruction - 3.7 - ND 
gross dilation of renal 
pelivis ureter dilated 
post wall bladder 
thickened 
+ 
19 Nagaraja 913269 63 M M ++ 
R
I
F
/
®
 
h
y
p
o
c
h
o
n
d
r
i
u
m
 
ON - + 8.6 RIF - - NAD B+ve 4.8 NAD UPG            TC Extensive dilated bowel ND 
20 Pannerselvam 868588 32 M M + LIF   VG - O 7.9   +
r
i
g
h
t
 
h
y
p
o
c
o
n
t
r
i
u
m
 
a
n
d
 
L
I
F
 
 - NAD O+ve 4 NAD ND 
Suprapubic collection 
(+) (M) 5x7cm in 
sigmoid liver 2o 
mesentric LN ⊕ 
+ 
21 Veeraiyan 830530 40 M M + - CN / D + O - - - + 4cm from AV (AV) UL not made out A+ve 3.8 NAD ND 
 thickening of Lower 
1/3 of rectum BaE ND 
22 Kunjammal 830130 40 F M + - CN / D + O - - - - 
Growth fixed 2cm from 
the AV finger could not 
be passed beyond 
O+ve 4.2 NAD ND 
Large mass displacing 
the rectumananal 
canal laterally GB 
calculus ⊕ 
BaE ND 
23 Annakkill 827641 21 F M +     +   -    11.6 - - - 
Growth occupying full 
lumen of rectum and 
anal canal 
AB+ve   NAD UPG          SC Growth - Lower 1/3 rectum + 
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Type of CA Diff 
S
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 Post OP Period Radio therapy Chemo therapy Follow up 
23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 
18 UR / MR + + Bladder ureter + + - ND Trans loop colostomy EM MD ADC C 
mild bleeding from 
the CY post 
operatively controlled 
otherwise UL 
Palliative chemo 
RT given NAD 
19 Heptic flexure and transverse colon N - Omentum - + - - 
extended ® hemi 
colectomy side to 
side anastomosis 
EM MD ADC B UL 1 course of chemo RT given given NAD 
20 SC + + (N) - - enlarged nodular surface D 
(L) Hemi colectomy 
Tr. Loop colostomy EL MD ADC C Prolonged ileus not given given 
admitted with abd 
distention 2 months 
later enema given 
colonoscopy normal
21 LR + - (N) - - - D APER EL PD ADC B UL not given - - 
22 LR - - - - - - - RT not willing for surgery - WD ADC C - Palliative RT - - 
23 LR Anal canal + + - - - (N) D APER EL Signet ring CA B/C cough + UL Pre OP neoadjuvant RT - pelvic pain 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
24 Jancy Rani 829934 30 F M - Abd. Dist + C + O 
+    
8.4 - - - 
Growth 7'o clock 9'o 
clock position 
moblie 
B+ve 3.9 NAD 
growth 
confirmed Bx 
taken 
Hypoechoric mass 
of 5.6x3.5cm 
inrectum and anal 
canal 
+ 
25 Lourdusamy 837848 50 M M - - CN + - +    6.2 - - - 
Growth involves 2/3 
 of rectum O+ve - NAD PG              LR
Post wall of 
bladder thickened + 
26 Ramaiyan 840948 65 M V - - - + O 9.2 -  + UPG in anorectum bleeding on touch B-ve 4 NAD - 
Liver enlarged 
mass Adhesions ⊕
free fluid ⊕ 
LFT (N) 
Bacnum (N) 
27 Abdul Razzak 840209 75 M M + - CN - - 9 - - -  growth 1cm from AV fixed B+ve 3.9 
NAD ® 
pleural 
effusion
Annular growth 
LR 
mixed ecogemic 
mass of 9x8cm in 
rectum 
+ 
28 Maheswari 858660 28 F M - - D - - 10.2
R
I
F
 
a
n
d
 
r
i
g
h
t
 
h
y
p
c
o
n
t
r
i
u
m
 
- (+) (A)  (+) PD NAD A1+ve 4.3 - UPG            AC ND LFT (N)           + 
29 Raju 858708 45 M M - - - - O +    6.9 -  - 
UPG1/2  of 
rectum AB+ve - - - ND LFT  
30 Arumujathammal 857610 50 F V +   CN / D - - 10.8  - - - - 
5cm from AV 
bleeds on touch 
post fornix growth ⊕
A+ve - NAD PG in rectum 
Rectal wall 
thickend no free 
fluid oravian cyst 
Blood sugar    
31 Kaliyan 861107 68 M M + 
L
I
F
 
?
 
F
e
c
o
l
i
t
h
 
D + - - - - - Stricture 3cm from th AV AB+ve - NAD - 
(L) hydrouretero 
nephrosis + 
32 Vasantha 859974 45 F M + - CN - O 10.2 - - - Polypoidal growth 3cm from AV B+ve 4.3 NAD ND 
Pelvicmass 
?ovary?nodes ND 
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 Post OP Period Radio therapy Chemo therapy Follow up 
23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 
24 
Lower 1/3 of 
rectum and Anal 
canal 
+ + - - - N D APER EL MD ADC B UL - - pelvic recurrance  at 6 months 
25 LR + + 
Posterior wall of 
bladder Inv. M. 
Noder ⊕ 
- - - D Sigmoid CY EM MD ADC C cough ⊕ UL Palliative RT - - 
26 LR Anal canal + + 
multiple adhesions in 
ant. Abd wall 
omentum 
+ + + - Sigmoid CY EM SQ CA C UL Chemo RT posto cisplatin 5 FU (6 cycles) - 
27 LR + + Bladder and ureter involved - - - - Sigmoid CY EL MD SQCA C UL Palliative RT 
chemo 5 fu 
cisplatin 
(6cycles) 
NAD 3 months 
28 AC + + + extenm deposits + - D Pallative bye pass EM MD ADC C 
U
L
 
w
o
u
n
d
 
i
n
f
e
c
t
i
o
n
 
w
o
u
n
d
 
g
a
p
i
n
g
 
a
n
d
 
2
o
 
s
u
t
u
r
i
n
g
 
d
o
n
e
 
Post op chemo 
salvage chiemo RT cisplatlin - 
29 UR / MR + + Bladder involved + - - ND Sigmoid Loop CY EM MD / PD mucinous AD C UL Palliative RT 
RT 5Fu 
cisplatlin NAD 3 months 
30 MR + + Post. Vag. Wall - + - D 
Exploratory 
Laparotomy 
oopherectomy 
EL WD ADC C UL Palliative RT Chemo RT 
severe neuralgic pain 
radiating down to leg. 
treated 
symptomatically 
31 LR + + Bladder post wall urter + - - - Sigmoid Loop CY EL ADC C UL External RT - pain / 3 months 
32 LR - - - - - - - Surgery deferred - 
Amelanotic 
melanoma of 
rectum 
C - Chemo RT Ref to GRH chennai - - 
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USG Abdomen and 
Pelvis 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
33 Sundarraj 860147 49 M M + - - + - + -  - 7cm from AV O+ve - NAD ND ND 
34 Bhakthavatchalam 829178 56 M M + - N - - + - - - - AB+ve - NAD Through CY done NAD ND 
35 Ramanujam 829178 60 M V - - 
I
n
c
o
n
t
i
n
e
n
t
 
+ - - - - -  indurated growth Anal canal B+ve - NAD ND 
Nodular mass in 
pelvis Lymphnodes 
enlarged 
36 Antony 829926 48 M M + - (N) + - -      9.6 - - - 
9cms anteriorly 
extending upto AV B+ve 3.6 NAD ND 
b/l hun  thickening 
of rectum and 
analcanal 
37 Shanthi 868062 38 F M + RIF VG - - 9.8 RIF - - NAD A+ve 4.1 NAD 
Thickening of 
ciecum and 
ascending CA 
thickening of rectal 
wall max 1.8 cm 
                     
                     
                     
 AV - Anal verge     −  increased   PR - Proximal rectum RIF - Right Iliac Fossa  
 UPG - Ulceroproliferitive growth ND -   Not done    MR -  Middle rectum LIF - Left Iliac Fossa  
 PG - Proliferitive growth CA -   Carcinoma   DR - Distal Rectum VG - Vomitting  
  - Circumference   ADC -  Adeno Carcinoma  WD - Well differentiated PD - Poorly differentiated 
 EL - Elective      EM -   Emergency   SEL - Semi Elective BaE - Barium enema 
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Type of CA Diff 
S
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 Post OP Period Radio therapy Chemo therapy Follow up 
23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 
33 - - - - - - - - - - ADC - - External Beam RT - - 
34 LR - - - - - - - APER (old case) El ADC - - ext RT - 22 day given - 
presented with B/L 
swelling of legs 
fever.     Palliative 
chemo given 
35 LR / Anal canal - - - - - - - - - ADC - - ext RT - 22 day given - severe pelvic pain ⊕ 
36 LR - - - - - - - - - MD ADC C - Palliative chemo RT - - 
37 AC - - - - - - - 
® hemi colectomy 
EE Ileo tramus 
anastomosis 
EL MD ADC B - ext RT given - - 
                 
                 
                 
 CN - Constipation  MD -  Moderately differentiated    V - Vegiterian   
 D - Diahorrea  APR -  Abdomino Perineal Resection   O - Obstruction   
 N -  Normal   M -  Mixed     NAD - No Abnormality detected  
 SQCA - Squamous Carcinoma  EE -  End to End    SS -  Side to Side   
 CY - Colostomy             
  
 
